Edoardo Cignoli : Sales Soar for Pricey Hepatitis Drug Sovaldi

A hepatitis C pill from Gilead Sciences that costs $1,000 a day is on track to notch among the biggest sales ever for the first year of a newly approved drug, showing how hard it is for insurers to curb usage.



via WSJ.com: US Business http://ift.tt/1dMcRQj